DOWN
ABOUT
INCE Capital is a global venture capital firm with an investment focus on early to expansion-stage companies that spearhead innovation in AI, technology, consumer, and biotech industries.
learn more
TEAM
NEWS
11.04
2026
Bambusa Therapeutics (Nasdaq: BBTX) Lists on Nasdaq Global Select Market October 30, 2026
04.13
2026
INCE Portfolio Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
01.14
2026
INCE Capital Portfolio Companies to Showcase at CES 2026
12.16
2025
JP Gan Ranks Among 2025 Forbes China's Top 100 Venture Capitalists